Quidel Corporation recalls QuickVue Dipstick Strep A Test
Product has the potential for false positive results
- Streptococcus Spp. All Groups Antigens
- Under Investigation by firm
The FDA has posted 6 enforcement recalls of streptococcus spp. all groups antigens devices since 2025, none of them Class I (most serious). Most recent report: May 20, 2026.
Product has the potential for false positive results
Product not cleared by the FDA.
Product not cleared by the FDA.
Product not cleared by the FDA.
Dipstick strep A test has potential for false positive results.
Due to a classification error in the inventory management system, specific medical devices were shipped to customers that did not have the requisite license to purchase such devices.
Source: U.S. FDA openFDA device enforcement reports, updated continuously. Device type per the FDA's RES classification (“Antigens, All Groups, Streptococcus Spp.”). Informational only — verify against the FDA before acting.